Kaarst Vorst, Germany

Klaus Gerdes

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sanochemia Pharmazeutika. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Klaus Gerdes. Retrieved from https://idiyas.com/inventor/klaus-gerdes-gg7zablc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klaus Gerdes - Innovator in Pharmaceutical Preparations

Introduction

Klaus Gerdes is a notable inventor based in Kaarst Vorst, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of contrast agents used in medical imaging.

Latest Patents

Klaus Gerdes holds a patent for a process for producing a contrast agent. This innovative process involves creating a pharmaceutical preparation that contains a complex of a lanthanide, specifically gadolinium, and a macrocyclic chelate, such as DOTA. This advancement is crucial for enhancing the quality of medical imaging.

Career Highlights

Klaus Gerdes is associated with Sanochemia Pharmazeutika, a company dedicated to pharmaceutical innovations. His work has been instrumental in advancing the field of medical imaging through the development of effective contrast agents.

Collaborations

Klaus has collaborated with notable colleagues, including József Gungl and Christina Abrahamsberg. Their combined expertise has contributed to the success of their projects and innovations in the pharmaceutical industry.

Conclusion

Klaus Gerdes is a distinguished inventor whose work in producing contrast agents has made a significant impact in the medical field. His contributions continue to enhance the effectiveness of medical imaging techniques.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…